| Dr William S Zirker, MD | |
|
1553 Chester Pike, Suite 201, Crum Lynne, PA 19022-1022 | |
| (610) 499-7180 | |
| (610) 499-7190 |
| Full Name | Dr William S Zirker |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 44 Years |
| Location | 1553 Chester Pike, Crum Lynne, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447321807 | NPI | - | NPPES |
| 001824510 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | MD071631L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health Care, Inc. | Media, PA | Home health agency |
| Southeastern Home Health Services | Bristol, PA | Home health agency |
| Ascend Hospice | Fort washington, PA | Hospice |
| Crozer Chester Medical Center | Upland, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prospect Health Access Network Inc | 5698065142 | 196 |
News Archive
The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.
CardioGenics Holdings Inc., a developer of technology and products targeting the immunoassay segment of the IVD testing market, reports that Merck Chimie S.A.S. ("Merck Chimie") is progressing to the next phase of the commercialization of CardioGenics' proprietary silver coated paramagnetic Beads ("Beads").
Alzheimer's disease drugs now being tested in clinical trials may have potentially adverse side effects, according to new Northwestern Medicine research. A study with mice suggests the drugs could act like a bad electrician, causing neurons to be miswired and interfering with their ability to send messages to the brain.
Northwest Biotherapeutics, a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced the closing of its previously-announced registered direct placement with healthcare focused institutional investors, for gross proceeds of $12.6 million on the terms previously announced.
ViroPharma Incorporated reported today its financial results for the third quarter ended September 30, 2010.
› Verified 1 days ago
| Entity Name | Prospect Health Access Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568819084 PECOS PAC ID: 5698065142 Enrollment ID: O20160613000737 |
News Archive
The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.
CardioGenics Holdings Inc., a developer of technology and products targeting the immunoassay segment of the IVD testing market, reports that Merck Chimie S.A.S. ("Merck Chimie") is progressing to the next phase of the commercialization of CardioGenics' proprietary silver coated paramagnetic Beads ("Beads").
Alzheimer's disease drugs now being tested in clinical trials may have potentially adverse side effects, according to new Northwestern Medicine research. A study with mice suggests the drugs could act like a bad electrician, causing neurons to be miswired and interfering with their ability to send messages to the brain.
Northwest Biotherapeutics, a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced the closing of its previously-announced registered direct placement with healthcare focused institutional investors, for gross proceeds of $12.6 million on the terms previously announced.
ViroPharma Incorporated reported today its financial results for the third quarter ended September 30, 2010.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William S Zirker, MD 1553 Chester Pike, Suite 201, Crum Lynne, PA 19022-1022 Ph: (610) 499-7180 | Dr William S Zirker, MD 1553 Chester Pike, Suite 201, Crum Lynne, PA 19022-1022 Ph: (610) 499-7180 |
News Archive
The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.
CardioGenics Holdings Inc., a developer of technology and products targeting the immunoassay segment of the IVD testing market, reports that Merck Chimie S.A.S. ("Merck Chimie") is progressing to the next phase of the commercialization of CardioGenics' proprietary silver coated paramagnetic Beads ("Beads").
Alzheimer's disease drugs now being tested in clinical trials may have potentially adverse side effects, according to new Northwestern Medicine research. A study with mice suggests the drugs could act like a bad electrician, causing neurons to be miswired and interfering with their ability to send messages to the brain.
Northwest Biotherapeutics, a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced the closing of its previously-announced registered direct placement with healthcare focused institutional investors, for gross proceeds of $12.6 million on the terms previously announced.
ViroPharma Incorporated reported today its financial results for the third quarter ended September 30, 2010.
› Verified 1 days ago
Joanne T Connaughton, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1553 Chester Pike, Suite 201, Crum Lynne, PA 19022 Phone: 610-499-7180 Fax: 610-876-0859 | |
Dr. Susan L Williams, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1553 Chester Pike, Crum Lynne, PA 19022 Phone: 610-499-7180 Fax: 610-876-0859 | |
Dr. Robert Lawrence Rudin, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1553 Chester Pike Ste 101, Crum Lynne, PA 19022 Phone: 610-690-4485 Fax: 610-876-9741 | |
Dr. Ashish V Rana, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1553 Chester Pike, Suite 201, Crum Lynne, PA 19022 Phone: 610-499-7180 Fax: 610-876-0859 | |
Dr. Deborah Kahn, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1553 Chester Pike, Crum Lynne, PA 19022 Phone: 610-499-7180 Fax: 610-876-0859 | |
John T Hippen, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1553 Chester Pike, Suite 201, Crum Lynne, PA 19022 Phone: 610-499-7180 Fax: 610-876-0859 |